Skip navigationU.S. Food and Drug Administration Center for Drug Evaluation and Research

CDER - Center for Drug Evaluation and Research Logo

Office of Generic Drugs

CDER Home Site Information Comments and Feedback What's New CDER Navigation Bar

Reference Listed Drug Labeling Approved in March 2001

Click on appropriate hyperlink below to view available source document in PDF format.

Approval Date

Product Name

Established Name

NDA No.

Supp.No.

Mar 1

LUPRON DEPOT 7.5 mg

letter

label

leuprolide acetate for injectable suspension 19-732 S-020
LUPRON DEPOT 3.75 mg

letter

label

leuprolide acetate for injectable suspension 20-011 S-020
LUPRON DEPOT 3 month 11.25 mg

letter

label

leuprolide acetate for injectable suspension 20-708 S-010
LUPRON DEPOT 4 month 30 mg

letter

label

leuprolide acetate for injectable suspension 20-517 S-010
LUPRON DEPOT 3 month 22.5 mg

letter

label

leuprolide acetate for injectable suspension 20-517 S-010

Mar 2

AXID

letter

label

nizatidine capsules

19-508

S-030

Mar 6

ALEVE

letter

label

naproxen sodium tablets

20-204

S-007

EPIVIR

letter

label

lamivudine tablets

lamivudine oral solution

20-564

20-596

S-012

S-013

NORVIR

letter

label

ritonavir oral solution

20-659

S-026

Mar 7

TEGRETOL

TEGRETOL-XR

letter

label

carbamazepine tablets

carbamazepine chewable tablets

carbamazepine oral suspension

carbamazepine extended-release tablets

16-608

18-281

18-927

20-234

S-090

S-039

S-031

S-017

Mar 8

PITOCIN

letter

label

oxytocin injection

18-261

S-020

URSO

letter

label

ursodiol tablets

20-675

S-007

Mar 13

KALETRA

letter

label

lopinavir/ritonavir capsules

lopinavir/ritonavir oral solution

21-226

21-251

S-002

S-002

REBETOL

letter

label

interferon alfa-2b (recombinant) for Injection/ribavirin

20-903

S-007

Mar 14

PEPCID tablets

letter

label

famotidine tablets

famotidine for oral suspension

famotidine orally disintegrating tablets

19-462

19-527

20-752

S-031

S-025

S-006

PEPCID injection

letter

label

famotidine injection

famotidine injection (premixed)

19-510

20-249

S-029

S-012

Mar 15

MELLARIL

MELLARIL-S

letter

label

thioridazine HCl tablets

thioridazine HCl oral suspension

11-808

17-923

S-178

S-049

PARNATE

letter

label

tranylcypromine sulfate tablets

12-342

S-051

SERENTIL

letter

label

mesoridazine besylate tablets

mesoridazine besylate injection

mesoridazine besylate oral solution

16-774

16-775

16-997

S-073

S-041

S-041

TRILAFON

letter

label

perphenazine tablets

perphenazine injection

10-775

11-213

S-029

S-021

Mar 21

ATARAX

letter

label

hydroxyzine HCl tablets

hydroxyzine HCl syrup

10-392

10-485

S-041

S-018

CRIXIVAN

letter

label

indinavir sulfate capsules

20-685

S-041

SERZONE

letter

label

nefazodone HCl tablets

20-152

S-026

VISTARIL

letter

label

hydroxyzine pamoate injection

hydroxyzine pamoate capsules

11-111

11-459

S-033

S-036

Mar 23

AGGRASTAT

letter

label

tirofiban hydrochloride injection

tirofiban hydrochloride injection

20-912

20-913

S-007

S-006

EULEXIN

letter

label

flutamide capsules

18-554

S-021

OVRAL

letter

label

norgestrel/ethinyl estradiol tablets

16-672

S-046

Mar 27

CYKLOKAPRON

letter

label

tranex acid injection

19-281

S-013

ELAVIL

letter

label

amitriptyline hydrochloride tablets

amitriptyline hydrochloride injection

12-703

12-704

S-092

S-045

NASALCROM

letter

label

cromolyn sodium nasal solution

20-463

S-002

NASAREL

letter

label

flunisolide nasal solution

20-409

S-006

SEROQUEL

letter

label

quetiapine fumarate tablets

20-639

S-011

Mar 29

FAMVIR

letter

label

famciclovir tablets

20-363

S-019

FLOVENT

letter

label

fluticasone propionate inhalation powder

20-549

S-008

Mar 30

BAYCOL

letter

label

cerivastatin sodium tablets

20-740

S-006

EULEXIN

letter

label

flutamide capsules

18-554

S-022

ORLAAM

letter

label

levomethadyl acetate HCl

20-315

S-006

RETROVIR

letter

label

zidovudine capsules

zidovudine tablets

19-655

20-518

S-032

S-004

ULTANE

letter

label

sevoflurane

20-478

S-006

 

FDA/Center for Drug Evaluation and Research
Last Updated: September 18, 200118 Jan 2006 17:16:38 -0500
Originator: OTCOM/DLIS
HTML by JFG